Feasibility of patient specific quality assurance for proton therapy based on independent dose calculation and predicted outcomes.

CONCLUSIONS: We demonstrated a feasibility to substitute PSQAM with PSQAIDC. In addition, we showed that PSQAIDC results can be interpreted in clinically more relevant manner, for instance using TCP / NTCP. PMID: 32579999 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32579999?dopt=Abstract

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - June 20, 2020 Category: Radiology Authors: Meijers A, Marmitt GG, Ng Wei Siang K, van der Schaaf A, Knopf AC, Langendijk JA, Both S Tags: Radiother Oncol Source Type: research